הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

br pharmaceuticals ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

br pharmaceuticals ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

ixl pharma ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

healthcare pharma ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

herbaceutica pharma ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

alissa healthcare research ltd - glucosamine sulfate; chondroitin sulfate - oral tablet

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - roxithromycin, quantity: 50 mg - tablet, dispersible - excipient ingredients: sodium lauryl sulfate; purified talc; fumaric acid; crospovidone; microcrystalline cellulose; methacrylic acid copolymer; colloidal anhydrous silica; triethyl citrate; macrogol 6000; saccharin sodium; sodium hydroxide; magnesium stearate; flavour - children: for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis, acute tonsilitis and impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine an organism's susceptibility and thus treatment suitability. therapy may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - glucosamine sulfate; chondroitin sulfate - oral tablet